← Leaderboards
Alex Goldstein
Syntrix Biosystems, Inc.
$657,183
Attributed
$657,183
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $275.4K · FY2005–08$500K$375K$250K$125K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$657,183 · 2
By mechanism
R43$657,183 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Germ Cells”
- Dennis R. Burton · Scripps Research Institute$42,000,000
- Philip J Disaia · University Of California Irvine$37,377,674
- Kc Kent Lloyd · University Of California At Davis$33,677,244
- John L Markley · University Of Wisconsin Madison$27,783,292
- Daniel Lowenstein · Beth Israel Deaconess Medical Center$26,416,844
- George M Church · Harvard University (Medical School)$26,252,489
Research focus
Germ CellsGonadotropinsFamily PlanningGaucher DiseaseAnabolismGlycosphingolipidsAnimalsAcrosomeAntigensFertilityCeramidesCerebrosidesAccountingColorCondoms, UnspecifiedContraceptive AgentsContraceptive Agents, MaleContraceptive MethodsCouplesCell MaturationCell MotilityDrug Design /Synthesis /ProductionEnzymesHormonal
Grant awards (4)
Male Nonhormonal Contraception Via Sphingolipid Biosynthesis Inhibitors$60,249
R43 · FY2008 · HD · contact PI
Male Nonhormonal Contraception Via Sphingolipid Biosynthesis Inhibitors$50,932
R43 · FY2007 · HD · contact PI
Novel Oral Trojan-Horse Agents for Osteolytic Cancer$275,412
R43 · FY2005 · CA
Novel Oral Trojan-Horse Agents for Osteolytic Cancer$270,590
R43 · FY2004 · CA